EPISODE · Sep 28, 2025 · 36 MIN
NRG-GU006 at the 2025 ASTRO Clinical Trials Session
from The NRG Oncology Podcast · host NRG Oncology
Our co-hosts discuss NRG-GU006 with Dr. Daniel Spratt. The results of NRG-GU006, a phase II clinical study in recurrent prostate cancer, were presented as a part of the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting Clinical Trials Session.
What this episode covers
Our co-hosts discuss NRG-GU006 with Dr. Daniel Spratt. The results of NRG-GU006, a phase II clinical study in recurrent prostate cancer, were presented as a part of the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting Clinical Trials Session.
NOW PLAYING
NRG-GU006 at the 2025 ASTRO Clinical Trials Session
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m